原发性肝癌导管化疗及部分脾栓的疗效分析

目的 探讨肝脾双介入疗法在原发性肝癌伴脾功能亢进中的临床应用价值。方法回顾性分析了2000年2月-2002年9月间采用肝脾双介入疗法治疗的肝癌合并脾亢患者的临床材料，方法均采用Seldinger技术穿刺股动脉后，先行肝动脉化疗栓塞，结束后，用脾栓导管行脾动脉栓塞，栓塞面积控制在30％-40％，栓塞制使用明腔海绵颗粒。结果肝脾双介入治疗后，患者WBC、PLT，RBC回升较快，缩短肝癌介入治疗的间隔时间。结论肝脾双介入疗法可以缓解脾亢，有效支持原发性肝癌的治疗。

Objective To study the value of the liver and spleen interventional therapy in primary cancinoma of the liver cancer with hypersplenism .Methods 32 patients of hepatocareinoma with hypersplenism after Hepatoeirrhosis from February 2000 to September 2002 were operated by partial splenic embolism using genlatin sponge granule＋ antibiotic aRer TACE （transpercutem hepatic arterial chemoembolization ） ,the area of embolism of spleen were controlled from 30% to 40%.Results ARer treatment of partial splenic embolism, the counts ofPLT, WBC and RBC are improved noticeably, so interval before next treatment is shorter more. Conclusion liver and spleen interwentional teherapy may relieve hypersplenism and suggests that the treatmen of primary carcinoma of the liver is effective.